DRUG POLICY ACTION (EIN 521951197) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Principal Officer

KASSANDRA FREDERIQUE

Phone

2126138040

Tax Period

2024-06-01 to 2025-05-31

DRUG POLICY ACTION, founded in 1995, is a community nonprofit in the Civil Rights & Advocacy sector that reported $8.6M in total revenue in fiscal year 2024. Revenue surged 63% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.6M, a strong 19% operating margin.

Mission

DRUG POLICY ACTION BELIEVES THAT THE REGULATION OF DRUGS SHOULD BE GROUNDED IN EVIDENCE, HEALTH, AND HUMAN RIGHTS. WE ADVOCATE FOR A HOLISTIC APPROACH TO DRUGS THAT PRIORITIZES HEALTH AND COMMUNITY WELLBEING. WE OPPOSE PUNITIVE APPROACHES THAT DESTABILIZE PEOPLE, BLOCK ACCESS TO CARE, AND DRAIN COMMUNITIES OF RESOURCES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $8,000,000

Program Service Revenue $0

Investment Income $567,034

Other Revenue $325

TOTAL REVENUE $8,567,359

Expense Breakdown

Grants Paid $6,605,000

Salaries & Benefits $0

Fundraising Expenses $44,601

Program Expenses $6,761,996

Other Expenses $338,741

TOTAL EXPENSES $6,943,741

Year-over-Year Comparison

	2024	2023	Change
Revenue	$8,567,359	$5,255,022	+0.6%
Expenses	$6,943,741	$2,373,132	+1.9%
Net Income	$1,623,618	$2,881,890	-0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✓ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$445,321

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DEREK OSCAR HODEL	PRESIDENT	2.00	Officer Director	$0	$0	$0
KENNETH T MONTEIRO	TREASURER	2.00	Officer Director	$0	$0	$0
SONDRA YOUDELMAN	SECRETARY	2.00	Officer Director	$0	$0	$0
JUAN CARTAGENA	DIRECTOR	1.00	Director	$0	$0	$0
PAMELA G LICHTY	DIRECTOR	1.00	Director	$0	$0	$0
KASSANDRA FREDERIQUE	EXECUTIVE DIRECTOR	8.00	Officer	$0	$44,444	$323,198
MELISSA GARCIA	CHIEF OPERATING OFFICER	8.00	Officer	$0	$23,715	$122,123

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$8,567,359	$6,943,741	$27,049,799	$1,623,618
2024	$5,255,022	$2,373,132	$19,735,187	$2,881,890
2023	$3,217,940	$5,989,024	$20,413,875	$-2,771,084
2022	$11,444,950	$3,394,764	$20,426,592	$8,050,186
2021	$3,054,408	$6,163,822	$10,522,161	$-3,109,414
2020	$2,712,321	$12,598,684	$14,019,338	$-9,886,363
2019	$1,931,367	$6,979,274	$23,259,228	$-5,047,907
2018	$953,436	$13,060,564	$28,219,930	$-12,107,128

DRUG POLICY ACTION